Home › Bids
› Secondary Analysis and Integration of Existing Data to Eluci
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Open145 days leftHealthcaregrant
Nov 18, 2024
Sep 7, 2026 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (PAR-25-096) from HHS-NIH supports secondary analysis and integration of existing data to understand cancer risk and related outcomes. Clinical trials are not allowed under this R21 grant.
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.